Maternal Health Diabetes Prevention Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Gestational DiabetesPreDiabetesHyperglycemiaGlucose Intolerance During Pregnancy
Interventions
BEHAVIORAL

Lifestyle Intervention

"The intervention has been modified from a subset of sessions from the National DPP Prevent T2 Curriculum (an adapted DPP for community settings that improves cardiometabolic outcomes and is implemented nationwide).~The intervention will consist of 8 weekly sessions. The first session will be one-on-one and subsequent sessions will be in small groups. Sessions 1, 2, and 6 will be in-person and other sessions will be held by Zoom."

Trial Locations (1)

70112

Tulane Office of Health Research, New Orleans

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Westat

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Tulane University

OTHER

NCT05343494 - Maternal Health Diabetes Prevention Study | Biotech Hunter | Biotech Hunter